1. Stang, A. & Jöckel, K. H. The impact of cancer screening on all-cause mortality: what is the best we can expect? Dtsch. Arztebl Int. 115, 481–486 (2018).
2. Loeb, S. et al. Overdiagnosis and overtreatment of prostate cancer. Eur. Urol. 65, 1046–1055 (2014).
3. Aizer, A. A. et al. Cost implications and complications of overtreatment of low-risk prostate cancer in the United States. J. Natl Compr. Cancer Netw. 13, 61–68 (2015).
4. Wang, M. C. et al. Purification of a human prostate specific antigen. Investig. Urol. 17, 159–163 (1979).
5. Papsidero, L. D. et al. A prostate antigen in sera of prostatic cancer patients. Cancer Res. 40, 2428–2432 (1980).